{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T23:37:27Z","timestamp":1717889847635},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T00:00:00Z","timestamp":1179878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2007,10,18]]},"DOI":"10.1007\/s10689-007-9139-7","type":"journal-article","created":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T10:34:52Z","timestamp":1179916492000},"page":"409-413","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic value of BRCA1 mutations in familial breast cancer patients affected by a second primary cancer"],"prefix":"10.1007","volume":"6","author":[{"given":"Pavel","family":"Elsakov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juozas","family":"Kurtinaitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerij","family":"Ostapenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,23]]},"reference":[{"key":"9139_CR1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT et\u00a0al (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692\u2013695","journal-title":"Lancet"},{"key":"9139_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/1097-0215(20001001)88:1<87::AID-IJC14>3.0.CO;2-F","volume":"88","author":"K Hemminki","year":"2000","unstructured":"Hemminki K, Vaittinen P, Easton D (2000) Familial cancer risks to offspring from mothers with 2 primary breast cancers: leads to cancer syndromes. Int J Cancer 88:87\u201391","journal-title":"Int J Cancer"},{"key":"9139_CR3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.1534","volume":"94","author":"H Evans","year":"2001","unstructured":"Evans H, Lewis C, Robinson D et al (2001) Cancer risks in women with 2 breast or ovarian cancers: clues to genetic cancer susceptibility. Int J Cancer 94:758\u2013759","journal-title":"Int J Cancer"},{"key":"9139_CR4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/gast.1996.v110.pm8608876","volume":"110","author":"R Sankila","year":"1996","unstructured":"Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP (1996) Better survival rates in patients with MLH1- associated hereditary colorectal cancer. Gastroenterology 110:682\u2013687","journal-title":"Gastroenterology"},{"key":"9139_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<373::AID-IJC12>3.0.CO;2-H","volume":"71","author":"A Percesepe","year":"1997","unstructured":"Percesepe A, Benatti P, Roncucci L, Sassatelli R, Fante R, Ganazzi D, Bellacosa A, Genuardi M, Neri G, Viel A, Ponz de Leon M (1997) Survival analysis in families affected be hereditary nonpolyposis colorectal cancer. Int J Cancer 71:373\u2013376","journal-title":"Int J Cancer"},{"key":"9139_CR6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF02235755","volume":"41","author":"KM Lin","year":"1998","unstructured":"Lin KM, Shashidharan M, Ternent CA, Thorson AG, Blatchford GJ, Christensen MA, Lanspa SJ, Lemon SJ, Watson P, Lynch HT (1998) Colorectal and extracolonic cancer variations in MLH1\/MSH2 hereditary nonopolyposis colorectal cancer kindreds and the general population. Dis Col Rec 41:428\u2013433","journal-title":"Dis Col Rec"},{"key":"9139_CR7","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/bjs.1800811038","volume":"81","author":"DE Porter","year":"1994","unstructured":"Porter DE, Cohen BB, Wallace MR et al (1994) Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome17q12\u201321. Br J Surg 81:1512\u20131515","journal-title":"Br J Surg"},{"key":"9139_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(98)00023-1","volume":"47","author":"DK Gaffney","year":"1998","unstructured":"Gaffney DK, Brohet RM, Lewis CM et al (1998) Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutation. Radiother Oncol 47:129\u2013136","journal-title":"Radiother Oncol"},{"key":"9139_CR9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jnci\/91.3.259","volume":"91","author":"JS Lee","year":"1999","unstructured":"Lee JS, Wacholder S, Struewing JP et al (1999) Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA 2 mutation carriers. J Natl Cancer Inst 91:259\u2013263","journal-title":"J Natl Cancer Inst"},{"key":"9139_CR10","first-page":"2465","volume":"3","author":"WD Foulkes","year":"1997","unstructured":"Foulkes WD, Wong N, Brunet JS, Begin LR, Zhang JC et al (1997) Germ-line BRCA1 mutation is an adverse prognosis factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 3:2465\u20132469","journal-title":"Clin Cancer Res"},{"key":"9139_CR11","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/jnci\/91.24.2112","volume":"91","author":"M Robson","year":"1999","unstructured":"Robson M, Levin D, Federici M, Satagopan J, Bogolminy F et al (1999) Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst 91:2112\u20132117","journal-title":"J Natl Cancer Inst"},{"key":"9139_CR12","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","volume":"359","author":"BG Haffty","year":"2002","unstructured":"Haffty BG, Harrold E, Khan AJ, Pathare P, Turner BC, Glazer PM, Ward B, Carter D, Matloff E, Bale AE, Alvarez-Franco M (2002) Outcome of conservatively managed early \u2013onset breast cancer by BRCA1\/2 STATUS. Lancet, 359:1471\u20131477","journal-title":"Lancet"},{"key":"9139_CR13","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1023\/A:1008301314812","volume":"10","author":"P O Chappuis","year":"1999","unstructured":"Chappuis P O, Rosenblatt J, Foulkes WD (1999) The influence of familial and hereditary factors on the prognosis of breast cancer. Ann Oncol 10:1163\u20131170","journal-title":"Ann Oncol"},{"key":"9139_CR14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-005-5150-6","volume":"94","author":"J Gronwald","year":"2005","unstructured":"Gronwald J, Elsakov P, Gorski B, Lubinski J (2005) High incidence of 4153delA BRCA1 gene mutation in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res Treat 94:111\u2013113","journal-title":"Breast Cancer Res Treat"},{"key":"9139_CR15","doi-asserted-by":"crossref","unstructured":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer (2000) Nov; 83(10):1301\u20131308","DOI":"10.1054\/bjoc.2000.1407"},{"issue":"11","key":"9139_CR16","first-page":"4259","volume":"6","author":"HA Shih","year":"2000","unstructured":"Shih HA, Nathanson KL, Seal S, Collins N, Stratton MR, Rebbeck TR, Weber BL (2000) BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Clin Cancer Res 6(11):4259\u20134264","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9139_CR17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10689-004-2758-3","volume":"4","author":"L Tikhomirova","year":"2005","unstructured":"Tikhomirova L, Sinicka O, Smite D, Eglitis J, Hodgson SV, Stengrevics A (2005) High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia. Fam Cancer. 4(2):77\u201384","journal-title":"Fam Cancer."},{"key":"9139_CR18","first-page":"683","volume":"110","author":"B Gorski","year":"2004","unstructured":"Gorski B, Jakubovska A, Huzarski T, Byrski T et al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families Int. J. Cancer 110:683\u2013686","journal-title":"J. Cancer"},{"key":"9139_CR19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1034\/j.1399-0004.2001.600611.x","volume":"60","author":"O Oszurek","year":"2000","unstructured":"Oszurek O, Gorski B, Gronvald J, Prosolow Z et al (2000) Founder mutation in the BRCA1 gene in west Belarussia breast-ovarian cancer families. Clin Genet 60:470\u2013471","journal-title":"Clin Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-007-9139-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-007-9139-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-007-9139-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:45:56Z","timestamp":1559252756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-007-9139-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,23]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10,18]]}},"alternative-id":["9139"],"URL":"https:\/\/doi.org\/10.1007\/s10689-007-9139-7","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,23]]}}}